Gray J. Bill would force drug makers to give customers data on risks. New York Times.July 25, 1996:A11.
D'Arcy PF, Griffin JP. Thalidomide revisited. Adverse Drug React Toxicol Rev.1994;13:65-76.
Cluff LE, Thornton CF, Seidl LG. Studies on the epidemiology of adverse drug reactions, part 1: methods
of surveillance. JAMA.1964;188:976-983.
Seidl LG, Thornton GF, Smith JW, Cluff LE. Studies on the epidemiology of adverse drug reactions, III: reactions
in patients on a general medical service. Johns Hopkins Hosp Bull.1966;119:299-315.
Borda IT, Slone D, Jick H. Assessment of adverse reactions within a drug surveillance program. JAMA.1968;205:99-101.
Miller RR. Hospital admissions due to adverse drug reactions: a report from the
Boston Collaborative Drug Surveillance Program. Arch Intern Med.1974;134:219-223.
Smith JW, Seidl LG, Cluff LE. Studies on the epidemiology of adverse drug reactions, V: clinical
factors influencing susceptibility. Ann Intern Med.1966;65:629-640.
World Health Organization. International Drug Monitoring: The Role of the Hospital. Geneva, Switzerland: World Health Organization; 1966. Technical Report
Series No. 425.
Bates DB, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized
adults. J Gen Intern Med.1993;8:289-294.
Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA.1975;234:1236-1241.
Chalmers TC, Smith H, Blackburn B.
et al. A method for assessing the quality of a randomized control trial. Control Clin Trials.1981;2:31-49.
Karch FE, Smith CL, Kerzner B, Mazzullo JM, Weintraub M, Lasagna L. Adverse drug reactions—a matter of opinion. Clin Pharmacol Ther.1976;19:489-92.
Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies:
a commentary. Am J Epidemiol.1995;142:371-382.
DerSimonian L, Laird N. Meta-analysis in clinical trials. Control Clin Trials.1986;7:177-188.
Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med.1995;14:395-411.
Einarson TR. Drug-related hospital admissions. Ann Pharmacother.1993;27:832-840.
Rosner B. Fundamentals of Biostatistics. 4th ed. New York, NY: Duxbury Press; 1995.
Morgan K, Morgan S, Quitno N. Health Care State Rankings 1996. 4th ed. Lawrence, Kan: Morgan Quitno Press; 1996.
Bates DW, Boyle DL, Vander Vliet MB, Scheider J, Leape LL. Relationship between medication errors and adverse drug reactions. J Gen Intern Med.1995;10:199-205.
Bates DW, Cullen DJ, Laird N.
et al. Incidence of adverse drug events and potential adverse drug events:
implications for prevention. JAMA.1995;274:29-34.
Bowman L, Carlstedt BC, Black CD. Incidence of adverse drug reactions in adult medical inpatients. Can J Hosp Pharm.1994;47:209-216.
Steel K, Gertman PM, Crescenzi C, Anderson J. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med.1981;304:638-642.
Mitchell AA, Goldman P, Shapiro S, Slone S. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol.1979;110:196-204.
Bennett BS, Lipman AG. Comparative study of prospective surveillance and voluntary reporting
in determining the incidence of adverse drug reactions. Am J Hosp Pharm.1977;34:931-936.
May FE, Fuller S, Stewart RB. Drug use and adverse drug reactions prior to and during hospitalization. J Am Pharm Assoc.1977;17:560-598.
Miller RR. Drug surveillance utilizing epidemiological methods: a report from
the Boston Collaborative Drug Surveillance Program. Am J Hosp Pharm.1973;30:584-592.
McKenzie MW, Stewart RB, Weiss CF, Cluff LE. A pharmacist-based study of the epidemiology of adverse drug reactions
in pediatric medicine patients. Am J Hosp Pharm.1973;30:898-903.
Wang R, Terry LC. Adverse drug reactions in a Veterans Administration hospital. J Clin Pharmacol New Drugs.1971;11:14-18.
Gardner P, Watson LJ. Adverse drug reactions: a pharmacist-based monitoring system. Clin Pharmacol Ther.1970;11:802-807.
Sidel VW, Koch-Weser J, Barnett GO, Eaton A. Drug utilization and adverse reactions in a general hospital. Hospitals.1967;41:80-88.
Reichel W. Complications in the care of five hundred elderly hospitalized patients. J Am Geriatr Soc.1965;13:973-977.
Schimmel EM. The hazards of hospitalization. Ann Intern Med.1964;60:100-110.
Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy.1996;16:701-707.
Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in
hospitalizations of the elderly. Arch Intern Med.1990;150:841-845.
Mitchell AA, Lacouture PG, Sheehan JE, Kauffman RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics.1988;82:24-29.
Bigby J, Dunn J, Goldman L.
et al. Assessing the preventability of emergency hospital admissions: a method
for evaluating the quality of medical care in a primary care facility. Am J Med.1987;83:1031-1036.
Lakshmanan MC, Hershey CO, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med.1986;146:1931-1934.
Salem RB, Keane TM, Williams JG. Drug-related admissions to a Veterans' Administration psychiatric unit. Drug Intell Clin Pharm.1984;18:74-76.
Stewart RB, Springer PK, Adams JE. Drug-related admissions to an inpatient psychiatric unit. Am J Psychiatry.1980;137:1093-1095.
Frisk PA, Cooper JW, Campbell NA. Community-hospital pharmacist detection of drug-related problems upon
patient admission to small hospitals. Am J Hosp Pharm.1977;34:738-742.
McKenney JM, Harrison WL. Drug-related hospital admissions. Am J Hosp Pharm.1976;33:792-795.
McKenzie MW, Marchall GL, Netzloff ML, Cluff LE. Adverse drug reactions leading to hospitalization in children. J Pediatr.1976;89:487-490.
Caranasos GJ, Stewart RB, Cluff LE. Drug-induced illness leading to hospitalization. JAMA.1974;228:713-717.
Rawlins M, Thompson J. Mechanisms of adverse drug reactions. In: Davies D, ed. Textbook of Adverse Drug Reactions.
4th ed. Oxford, England: Oxford University Press; 1991.
Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalized
medical patients? J Am Geriatr Soc.1991;39:1093-1099.
Hurwitz N, Wade OL. Intensive hospital monitoring of adverse reactions to drugs. BMJ.1969;1:531-536.
Ogilvie RI, Ruedy J. Adverse drug reactions during hospitalization. Can Med Assoc J.1967;97:1450-1457.
Domecq C, Naranjo CA, Ruiz I, Busto U. Sex-related variations in the frequency and characteristics of adverse
drug reactions. Int J Clin Pharmacol Ther Toxicol.1980;18:362-366.
Zilleruelo I, Espinoza E, Ruiz I. Influence of the assessment of the severity on the frequency of adverse
drug reactions. Int J Clin Pharmacol Ther Toxicol.1987;25:328-333.
National Center for Health Statistics. National Hospital Discharge Survey: Annual Summary, 1992. Hyattsville, Md: US Dept of Health and Human Services; 1994. Publication
Kahn L, Rubenstein L, Draper D.
et al. The effects of the DRG-based prospective payment system on quality
of care for hospitalized medicare patients. JAMA.1990;264:1953-1955.
Hurwitz N. Predisposing factors in adverse drug reactions to drugs. BMJ.1969;1:536-539.
Smidt NA, McQueen EG. Adverse reactions to drugs: a comprehensive hospital inpatient survey. N Z Med J.1972;76:397-401.
Smidt NA, McQueen EG. Adverse drug reactions in a general hospital. N Z Med J.1973;78:39.
O'Hara D, Carson N. Reporting of adverse events in hospitals in Victoria, 1994-1995. Med J Aust.1997;166:460-463.
Evans RC, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother.1994;28:523-527.
Classen DC, Pestonik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay,
extra costs, and attributable mortality. JAMA.1997;277:301-306.
Bates DW, Spell N, Cullen DJ.
et al. The costs of adverse drug events in hospitalized patients. JAMA.1997;277:307-311.
American Hospital Association. Hospital Statistics, 1993-1994. Chicago, Ill: American Hospital Association; 1994.